ArticleMolecular biology and evolution2025
Spectral Tuning in Mammalian Melanopsins.
Article in Molecular biology and evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nocturnal Dim Blue Light Is Associated with Splenic Immune Dysregulation and Altered CORT-GR Signalling in High-Fat-Diet-Fed Mice.Antioxidants (Basel, Switzerland) · 2026Article
- Minimal Mimics and Maps of Natural Light for Mammals.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Melanopsin is a light-sensitive G-protein coupled receptor responsible for essential visual and non-visual light-mediated behaviors in mammals. Human melanopsin shows maximal sensitivity (λmax) in the blue region of the spectrum (∼480 nm), and available evidence suggests that this spectral sensitivity may be retained across mammals. However, melanopsin spectral sensitivity has been defined for only a small number of species, and the molecular mechanisms determining this property remain poorly understood. Here, we use heterologous action spectroscopy to determine the spectral sensitivity of melanopsins from 8 mammalian species, selected to cover diversity in retinal physiology, lighting niche, and evolutionary distance, and of engineered mutants of mouse melanopsin designed to explore mechanisms of spectral tuning. We find that melanopsin λmax varies by only 23 nm across tested mammalian species and that, within this range, it is not strongly predicted by phylogeny, retinal physiology, or lighting niche. Mutation of residues predicted to shift the electrostatic environment of the chromophore was successfully applied to produce long and short wavelength shifts in the spectral sensitivity of mouse melanopsins. However, neither natural diversity in melanopsin λmax nor the magnitude of shifts produced by mutagenesis could be adequately predicted by mechanisms of spectral tuning established in vertebrate visual or invertebrate opsins. Our data indicate that melanopsin spectral sensitivity is constrained across mammalian species via molecular mechanisms that are substantially distinct from those defined in other branches of the opsin family.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.